Joint development and creation of new businesses through a capital and business alliance with Sanyo Chemical Industries
First written in FY2021-Q2. 4 of 6 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「In 2025, efficacy was demonstrated at 16 rice paddies nationwide, and yields increased by up to 12% versus conventional cultivation at paddies in Kyoto, Kumamoto and Toyama, steadily demonstrating the effectiveness of the Company's formulation.」
The biostimulant program progressed to the stage of demonstrations at 16 paddies nationwide and confirmation of yield increases of up to 12%. - FY2023AdvancedAnnual report
「In R&D for the Agri-Nutrition business, the company conducted tests of the yield and harvest timing of biostimulants, a new type of agricultural material, at more than 10 fields nationwide.」
Under the Agri-Nutrition plan with SANYO CHEMICAL, the company conducted demonstration tests of biostimulants at more than 10 fields nationwide. - FY2022AdvancedAnnual report
「The initiative aims to solve agricultural challenges by developing biostimulants, materials that stimulate crops to improve their quality and resilience, with practical application targeted for around 2024 and, over the longer term, the development of a sustainable agricultural system.」
The Basic Plan for Agri-Nutrition with SANYO CHEMICAL sets out a timeline for developing biostimulants and achieving practical application around 2024. - FY2022-Q1AdvancedAnnual report
「In R&D, the company formulated the “Basic Plan for Agri-Nutrition” with SANYO CHEMICAL INDUSTRIES,LTD. in September 2021. During the first quarter cumulative consolidated period, the two companies discussed a research plan for peptide-based agriculture toward the start of demonstration testing in 2022. They also produced prototypes using unused resources, including eggshells and eggshell membranes, with a view to commercializing chemical products.」
Under the alliance with SANYO CHEMICAL, the companies formulated the Basic Plan for Agri-Nutrition and moved on to discussions of a research plan for peptide-based agriculture and the production of prototypes using unused resources, toward the start of demonstration testing in 2022. - FY2021-Q3RaisedAnnual report
「① Joint development of raw materials for the company’s products, including “Neumo Vactory ShampooⓇ,” and production and supply of those raw materials by SANYO CHEMICAL ② Drug development through the integration of the company’s chicken-derived humanized antibody production technology, “ALAgeneⓇ technology (Aladdin Technology),” and SANYO CHEMICAL’s polymer-modification technologies using polyethylene glycol for pharmaceutical applications ③ Creation of new businesses by promoting open innovation aimed at integrating the two companies’ technologies from different fields and mutually leveraging their customer networks ④ Joint social-contribution activities by the company and SANYO CHEMICAL’s Katsura Research Institute in and around Kyoto University’s Katsura Campus」
The alliance with SANYO CHEMICAL now expressly covers social-contribution activities around Kyoto University’s Katsura Campus, in addition to joint raw-material development, drug discovery and new business creation, expanding the scope of the alliance. - FY2021-Q2First statedAnnual report
「The company and SANYO CHEMICAL have agreed to pursue a strategic business alliance covering the following areas. The specific policies and details of the alliance will be determined through consultation between the two companies. ① Joint development of raw materials for the company’s products, including “Neumo Vactory ShampooⓇ,” and production and supply of those raw materials by SANYO CHEMICAL ② Drug development through the integration of the company’s “ALAgeneⓇ technology (Aladdin Technology)” and SANYO CHEMICAL’s polymer-modification technologies using polyethylene glycol for pharmaceutical applications ③ Creation of new businesses by promoting open innovation between the two companies and mutually leveraging their customer networks」
On 15 March 2021, the company entered into a capital and business alliance agreement with SANYO CHEMICAL INDUSTRIES,LTD. The companies will cooperate on the joint development, production and supply of product raw materials; drug development combining ALAgene technology and polymer-modification technology; and the creation of new businesses leveraging open innovation and their customer networks. The framework also includes plans for each company to acquire shares in the other, with a target total amount of ¥200 million for each company.